文献速递淋巴瘤

淋巴瘤诊断前后体力活动与生存结局的关联

The association of physical activity before and after lymphoma diagnosis with survival outcomes.
PubMed 文献 · Am J Hematol · 2018-10-17

该前瞻性队列纳入2002—2012年新诊断淋巴瘤患者,评估诊断前(基线)与诊断后3年体力活动及变化与总生存、淋巴瘤特异性生存和事件无生存的关联。诊断时及3年时活动量较高与总生存、淋巴瘤特异性生存和事件无生存显著相关;诊断后活动量增加与总生存和淋巴瘤特异性生存改善显著相关。

要点

  • 基线活动达标者总生存HR 0.82(0.72-0.94)、淋巴瘤特异性生存HR 0.74(0.61-0.90)。
  • 诊断后3年活动达标者总生存HR 0.64(0.46-0.88)、淋巴瘤特异性生存HR 0.32(0.18-0.59)。
  • 诊断后活动量增加与总生存HR 0.70(0.49-1.00)和淋巴瘤特异性生存HR 0.49(0.26-0.94)相关。

核心结论

  • 淋巴瘤患者诊断时及诊断后3年体力活动较高与总生存、淋巴瘤特异性生存和事件无生存显著相关。
  • 诊断后体力活动增加与总生存和淋巴瘤特异性生存改善显著相关,支持体力活动在淋巴瘤生存者中的重要作用及干预试验的必要性。

研究设计与样本

  • 体力活动采用自报的成人常规体力活动计算休闲活动评分指数(mLSI),按美国癌症协会体力活动指南分为活动达标与活动不足。
  • 采用Cox模型按淋巴瘤亚型分层,校正年龄、性别、基线BMI和合并症评分,变化评分进一步校正基线体力活动。

主要发现

  • 基线活动达标者较活动不足者总生存HR 0.82(95%CI 0.72-0.94)、淋巴瘤特异性生存HR 0.74(95%CI 0.61-0.90)、事件无生存HR 0.92(95%CI 0.82-1.02)。
  • 诊断后3年活动达标者较活动不足者总生存HR 0.64(95%CI 0.46-0.88)、淋巴瘤特异性生存HR 0.32(95%CI 0.18-0.59)、事件无生存HR 0.82(95%CI 0.61-1.10)。
  • mLSI从基线至3年增加(对比mLSI稳定)与总生存HR 0.70(95%CI 0.49-1.00)和淋巴瘤特异性生存HR 0.49(95%CI 0.26-0.94)相关。
  • 3年时mLSI的连续变化与总生存、淋巴瘤特异性生存和事件无生存显著相关,且在各亚组中保持一致并呈线性。

关键数值与推荐

  • 体力活动分组依据美国癌症协会体力活动指南,分为活动达标与活动不足。
  • 基线活动达标与总生存HR 0.82(95%CI 0.72-0.94)、淋巴瘤特异性生存HR 0.74(95%CI 0.61-0.90)、事件无生存HR 0.92(95%CI 0.82-1.02)相关。
  • 3年时活动达标与总生存HR 0.64(95%CI 0.46-0.88)、淋巴瘤特异性生存HR 0.32(95%CI 0.18-0.59)、事件无生存HR 0.82(95%CI 0.61-1.10)相关。
  • mLSI增加与总生存HR 0.70(95%CI 0.49-1.00)和淋巴瘤特异性生存HR 0.49(95%CI 0.26-0.94)相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The impact of physical activity (PA) on lymphoma survival is not known. The association of PA and change in PA with overall (OS), lymphoma-specific (LSS) and event-free (EFS) survival was evaluated in a prospective cohort of newly diagnosed lymphoma patients (2002-2012). We calculated Leisure Score Indexes (mLSI) from the self-reported usual adult PA (baseline) and at 3-years post-diagnosis (FU3), grouping patients by active vs insufficiently active by the American Cancer Society PA guidelines. Associations of PA with survival were assessed using hazard ratios (HRs) and 95% confidence intervals (CI) from Cox models stratified by lymphoma subtype, adjusted for age, sex, baseline BMI, and comorbidity score with change scores further adjusted for baseline PA. Three thousand sixty participants were evaluable at baseline and 1371 at FU3. Active patients had superior survival from baseline [HR (CI): OS 0.82 (0.72-0.94); LSS 0.74 (0.61-0.90); EFS 0.92 (0.82-1.02)] and FU3 [HR (CI): OS 0.64 (0.46-0.88); LSS 0.32 (0.18-0.59); EFS 0.82 (0.61-1.10)] compared to insufficiently active. An increase in mLSI from baseline to FU3 (vs stable mLSI) was associated with superior OS (HR = 0.70, CI 0.49-1.00) and LSS (HR = 0.49, CI 0.26-0.94).The continuous change in mLSI at FU3 was significantly associated with OS, LSS and EFS; maintained across subgroups and appeared linear. Higher PA among lymphoma patients at diagnosis and 3 years is significantly associated with OS, LSS, and EFS. Increasing PA after diagnosis is significantly associated with improved OS and LSS supporting an important role for PA in lymphoma survivorship and the need for intervention trials.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Pophali PA, Ip A, Larson MC, et al. The association of physical activity before and after lymphoma diagnosis with survival outcomes. Am J Hematol. 2018. PMID: 30230581. doi:10.1002/ajh.25288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。